CMV pp52 Antibodies

Santa Cruz Biotechnology offers a broad range of CMV pp52 Antibodies for studying cytomegalovirus (CMV) protein pp52. CMV pp52 Antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CMV pp52 protein plays a crucial role in the viral life cycle, contributing to viral replication and immune evasion. Understanding CMV pp52 function is essential for developing therapeutic strategies against CMV infections, which can lead to significant health complications, particularly in immunocompromised individuals. CMV infections remain a significant public health concern, affecting millions of people worldwide. Ongoing research continues to uncover new aspects of CMV pp52's role in viral pathogenesis. Investigating CMV pp52 helps reveal potential therapeutic targets and advances our understanding of viral mechanisms. Santa Cruz Biotechnology monoclonal antibodies for CMV pp52 support researchers in their mission to develop effective treatments for CMV-related diseases.